TIGER MANAGEMENT L.L.C. - ALPINE IMMUNE SCIENCES INC ownership

ALPINE IMMUNE SCIENCES INC's ticker is ALPN and the CUSIP is 02083G100. A total of 49 filers reported holding ALPINE IMMUNE SCIENCES INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
TIGER MANAGEMENT L.L.C. ownership history of ALPINE IMMUNE SCIENCES INC
ValueSharesWeighting
Q1 2022$1,235,000
-35.3%
137,7280.0%0.20%
-45.5%
Q4 2021$1,908,000
+29.8%
137,7280.0%0.37%
+37.5%
Q3 2021$1,470,000
+18.5%
137,7280.0%0.27%
+25.3%
Q2 2021$1,240,000
-15.1%
137,7280.0%0.22%
-24.4%
Q1 2021$1,460,000
-15.9%
137,7280.0%0.29%
-27.2%
Q4 2020$1,735,000
+43.3%
137,7280.0%0.39%
+14.2%
Q3 2020$1,211,000
-9.4%
137,7280.0%0.34%
-6.5%
Q2 2020$1,337,000
+236.8%
137,7280.0%0.37%
+177.4%
Q1 2020$397,000
-25.0%
137,7280.0%0.13%
-11.3%
Q4 2019$529,000
-2.9%
137,7280.0%0.15%
-27.5%
Q3 2019$545,000
-6.0%
137,7280.0%0.21%
-11.9%
Q2 2019$580,000
-38.6%
137,7280.0%0.24%
-9.6%
Q1 2019$945,000
+57.8%
137,728
-15.4%
0.26%
+71.1%
Q4 2018$599,000
-41.8%
162,7280.0%0.15%
+47.6%
Q3 2018$1,030,000
-16.4%
162,7280.0%0.10%
-58.5%
Q2 2018$1,232,000
-5.4%
162,7280.0%0.25%
+48.5%
Q1 2018$1,302,000
-28.6%
162,7280.0%0.17%
-41.4%
Q4 2017$1,823,000
-3.4%
162,7280.0%0.28%
-16.7%
Q3 2017$1,888,000162,7280.34%
Other shareholders
ALPINE IMMUNE SCIENCES INC shareholders Q1 2021
NameSharesValueWeighting ↓
FRAZIER MANAGEMENT LLC 2,571,450$17,640,0004.25%
BVF INC/IL 1,201,717$8,244,0000.92%
Orbimed Advisors 3,670,955$25,183,0000.39%
TIGER MANAGEMENT L.L.C. 137,728$945,0000.26%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 475,450$3,262,0000.12%
Hikari Power Ltd 122,972$844,0000.09%
ALPINE WOODS CAPITAL INVESTORS, LLC 15,000$103,0000.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 35,750$245,0000.00%
DRW Securities, LLC 10,000$69,0000.00%
VICTORY CAPITAL MANAGEMENT INC 134,542$923,0000.00%
View complete list of ALPINE IMMUNE SCIENCES INC shareholders